Our novel ensilication technology exploits the growth of protective silica nanoshells on the surface of biological components, to prevent degradation, which can lead to spoilage.

Once applied, our products can be stored and transported without the need for cold chain infrastructure, preventing wastage, improving shelf-life and increasing the accessibility of biological therapeutics and diagnostics globally.

Unlike other stabilisation technologies, our technology does not rely on lyophilisation or any harsh conditions. This makes it ideal for the preservation of delicate biologicals.